U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07647575) titled 'Hypertonic Saline Inhalation for Nontuberculous Mycobacterial Lung Disease' on June 06.
Brief Summary: This multicenter randomized controlled trial evaluates the clinical and microbiological effects of inhaled 3% hypertonic saline in treatment-naive patients with nontuberculous mycobacterial lung disease (NTM-LD). Participants are randomized in a 1:1 ratio to either early initiation of 3% hypertonic saline for 6 months or delayed initiation consisting of normal saline inhalation during the first 3 months followed by 3% hypertonic saline during the subsequent 3 months.
The primary objective is to compare respiratory symptom improvem...